Filing search / Ownership / Recursion Pharmaceuticals, Inc. / Page 6

8-K

w8jig59e 91

13 Jul 21

Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD

8:18am

10-Q

1bylkgr2lt3rxd

12 May 21

Quarterly report

8:47am

8-K

1nz23j wtyjc

12 May 21

Recursion Reports First Quarter 2021 Financials and Provides Business Updates

8:46am

8-K

02hl9p

21 Apr 21

Recursion Pharmaceuticals Announces Closing of Initial Public Offering

9:08am

S-8

oh0r btuwqkc2hn

16 Apr 21

Registration of securities for employees

5:02pm

EFFECT

4wxrogdmd

16 Apr 21

Notice of effectiveness

12:15am

424B4

o7rf ynx3p

16 Apr 21

Prospectus supplement with pricing info

12:00am

S-1MEF

yk5ra8j 5cb

15 Apr 21

Registration of additional securities for an S-1

8:59pm

CERT

zi99d g0l87vx94ep

15 Apr 21

Certification of approval for exchange listing

3:24pm

SEC STAFF

wfezlt1494mix

15 Apr 21

SEC staff action: Order

12:00am

CORRESP

fs9fwb

13 Apr 21

Correspondence with SEC

12:00am

CORRESP

5s0o5

13 Apr 21

Correspondence with SEC

12:00am

S-1/A

wltjkz

12 Apr 21

IPO registration (amended)

6:11am

8-A12B

p6oejrwk

12 Apr 21

Registration of securities on exchange

6:10am

SEC STAFF

2pzlxv7

25 Mar 21

SEC staff action: Order

12:00am

S-1

axp9kk8liz8

22 Mar 21

IPO registration

4:33pm

CORRESP

t4jtoqtuhu

22 Mar 21

Correspondence with SEC

12:00am

UPLOAD

8i1 m0m40y7mdpe

19 Mar 21

Letter from SEC

12:00am

DRSLTR

r3raa2a53 1jys

3 Mar 21

Correspondence regarding draft registration statement

12:00am